Exhibit
4.1


 


Description
of Securities Registered Pursuant to


Section
12 of the Securities Exchange Act of 1934, as amended


 


General


 


Our
authorized capital stock consists of 200,000,000 shares of common stock, $0.02 par value per share, 62,086,099 of which were issued
and outstanding as of March 20, 2020.


 


The
following description of our common stock summarizes the material terms and provisions of the common stock that we may offer under
this prospectus but is not complete. For the complete terms of our common stock, please refer to our certificate of incorporation,
as amended, (the “Certificate of Incorporation”) which may be further amended from time to time, and our fifth amended
and restated by-laws, as further amended from time to time (the “By-laws”). The New York Business Corporation Law
(“NYBCL”) may also affect the terms of these securities.


 


Holders
of our common stock: (i) have equal rights to dividends from funds legally available therefore, ratably when as and if declared
by the Company’s board of directors; (ii) are entitled to share ratably in all assets of the Company available for distribution
to holders of common stock upon liquidation, dissolution, or winding up of the affairs of the Company; (iii) do not have preemptive,
subscription or conversion rights and there are no redemption or sinking fund provisions applicable thereto; (iv) are entitled
to one non-cumulative vote per share of common stock, on all matters which stockholders may vote on at all meetings of stockholders;
and (v) the holders of common stock have no conversion, preemptive or other subscription rights. There is no cumulative voting
for the election of directors. Each holder of our common stock is entitled to one vote for each share of our common stock held
on all matters submitted to a vote of stockholders.


 


Anti-Takeover
Effects of Certain Provisions of our Certificate of Incorporation, By-laws and the NYBCL


 


Section
912 of the NYBCL generally provides that a New York corporation may not engage in a business combination with an interested stockholder
for a period of five years following the interested stockholder’s becoming such. Such a business combination would be permitted
where it is approved by the board of directors before the interested stockholder’s becoming such. Covered business combinations
include certain mergers and consolidations, dispositions of assets or stock, plans for liquidation or dissolution, reclassifications
of securities, recapitalizations and similar transactions. An interested stockholder is generally a stockholder owning at least
20% of a corporation’s outstanding voting stock. In addition, New York corporations may not engage at any time with any
interested stockholder in a business combination other than: (i) a business combination approved by the board of directors before
the stock acquisition, or where the acquisition of the stock had been approved by the board of directors before the stock acquisition;
(ii) a business combination approved by the affirmative vote of the holders of a majority of the outstanding voting stock not
beneficially owned by the interested stockholder at a meeting called for that purpose no earlier than five years after the stock
acquisition; or (iii) a business combination in which the interested stockholder pays a formula price designed to ensure that
all other stockholders receive at least the highest price per share that is paid by the interested stockholder and that meets
certain other requirements.


 


A
corporation may opt out of the interested stockholder provisions described in the preceding paragraph by expressly electing not
to be governed by such provisions in its by-laws, which must be approved by the affirmative vote of a majority of votes of the
outstanding voting stock of such corporation and is subject to further conditions. However, our By-laws do not contain any provisions
electing not to be governed by Section 912 NYBCL. Under our By-laws, any corporate action to be taken by vote of the shareholders,
shall be authorized by a majority of votes cast at a meeting of shareholders by the holders of shares entitled to vote thereon.


 


Transfer
Agent and Registrar


 


The
Transfer Agent and Registrar for our common stock is American Stock Transfer and Trust Company, LLC, 6201 15th Ave., Brooklyn,
NY 11219, USA, +1-800-937-5449 or +1-718-921-8124.


 


Listing


 


Our
Common Stock is listed on the New York Stock Exchange under the ticker symbols “DSS.”